US Visa Concerns Led ICH To Choose Canadian Meeting Site
Executive Summary
The US, one of ICH’s original three member authorities, was spurned in favor of Canada for the pharmaceutical regulatory harmonization initiative’s next meeting in the region because of some participants’ difficulties obtaining US visas.